Hynes NE - Search Results

1

Ret Receptor Has Distinct Alterations and Functions in Breast Cancer.

Gattelli A, Hynes NE, Schor IE, Vallone SA. Gattelli A, et al. Among authors: hynes ne. J Mammary Gland Biol Neoplasia. 2020 Mar;25(1):13-26. doi: 10.1007/s10911-020-09445-4. Epub 2020 Feb 21. J Mammary Gland Biol Neoplasia. 2020. PMID: 32080788 Review.

2

Ret inhibition decreases growth and metastatic potential of estrogen receptor positive breast cancer cells.

Gattelli A, Nalvarte I, Boulay A, Roloff TC, Schreiber M, Carragher N, Macleod KK, Schlederer M, Lienhard S, Kenner L, Torres-Arzayus MI, Hynes NE. Gattelli A, et al. Among authors: hynes ne. EMBO Mol Med. 2013 Sep;5(9):1335-50. doi: 10.1002/emmm.201302625. Epub 2013 Jul 19. EMBO Mol Med. 2013. PMID: 23868506 Free PMC article.

3

Chronic expression of wild-type Ret receptor in the mammary gland induces luminal tumors that are sensitive to Ret inhibition.

Gattelli A, García Solá ME, Roloff TC, Cardiff RD, Kordon EC, Chodosh LA, Hynes NE. Gattelli A, et al. Among authors: hynes ne. Oncogene. 2018 Jul;37(29):4046-4054. doi: 10.1038/s41388-018-0235-y. Epub 2018 Apr 26. Oncogene. 2018. PMID: 29695833

4

Aberrant RET expression affects normal mammary gland post-lactation transition, enhancing cancer potential.

Vallone SA, García Solá M, Schere-Levy C, Meiss RP, Hermida GN, Chodosh LA, Kordon EC, Hynes NE, Gattelli A. Vallone SA, et al. Among authors: hynes ne. Dis Model Mech. 2022 Mar 1;15(3):dmm049286. doi: 10.1242/dmm.049286. Epub 2022 Mar 29. Dis Model Mech. 2022. PMID: 35044452 Free PMC article.

5

P-Rex1, a guanine exchange factor that is overexpressed in breast cancer, is a convergence node for ErbB and CXCR4 signaling.

Hynes NE, Gattelli A. Hynes NE, et al. Mol Cell. 2011 Jan 7;41(1):5-7. doi: 10.1016/j.molcel.2010.12.024. Mol Cell. 2011. PMID: 21211718 Free article.

6

Decreased NK-cell tumour immunosurveillance consequent to JAK inhibition enhances metastasis in breast cancer models.

Bottos A, Gotthardt D, Gill JW, Gattelli A, Frei A, Tzankov A, Sexl V, Wodnar-Filipowicz A, Hynes NE. Bottos A, et al. Among authors: hynes ne. Nat Commun. 2016 Jul 13;7:12258. doi: 10.1038/ncomms12258. Nat Commun. 2016. PMID: 27406745 Free PMC article.

7

Molecular aspects of breast cancer.

Hynes N, Dickson RB. Hynes N, et al. J Mammary Gland Biol Neoplasia. 1996 Apr;1(2):137-8. doi: 10.1007/BF02013637. J Mammary Gland Biol Neoplasia. 1996. PMID: 10887487 No abstract available.

8

Myc and mammary cancer: Myc is a downstream effector of the ErbB2 receptor tyrosine kinase.

Hynes NE, Lane HA. Hynes NE, et al. J Mammary Gland Biol Neoplasia. 2001 Jan;6(1):141-50. doi: 10.1023/a:1009528918064. J Mammary Gland Biol Neoplasia. 2001. PMID: 11467449 Review.

9

Expression of the mRNA stability regulator Tristetraprolin is required for lactation maintenance in the mouse mammary gland.

Goddio MV, Gattelli A, Tocci JM, Cuervo LP, Stedile M, Stumpo DJ, Hynes NE, Blackshear PJ, Meiss RP, Kordon EC. Goddio MV, et al. Among authors: hynes ne. Oncotarget. 2018 Jan 3;9(9):8278-8289. doi: 10.18632/oncotarget.23904. eCollection 2018 Feb 2. Oncotarget. 2018. PMID: 29492194 Free PMC article.

10

The mTOR pathway in breast cancer.

Hynes NE, Boulay A. Hynes NE, et al. J Mammary Gland Biol Neoplasia. 2006 Jan;11(1):53-61. doi: 10.1007/s10911-006-9012-6. J Mammary Gland Biol Neoplasia. 2006. PMID: 16900391 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

224 results

Search Page